Carol L Brosgart - Net Worth and Insider Trading
Carol L Brosgart Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carol L Brosgart owns 3 companies in total, including Renovaro Inc (RENB) , Regado Biosciences Inc (RGDO) , and Mirum Pharmaceuticals Inc (MIRM) .
Click here to see the complete history of Carol L Brosgart’s form 4 insider trades.
Insider Ownership Summary of Carol L Brosgart
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RENB | Renovaro Inc | 2019-12-27 | director |
RGDO | Regado Biosciences Inc | 2016-11-01 | director |
MIRM | Mirum Pharmaceuticals Inc | 2021-06-04 | director |
Carol L Brosgart Trading Performance
Carol L Brosgart Ownership Network
Ownership Network List of Carol L Brosgart
Ownership Network Relation of Carol L Brosgart
Carol L Brosgart Owned Company Details
What does Renovaro Inc do?
Who are the key executives at Renovaro Inc?
Carol L Brosgart is the director of Renovaro Inc. Other key executives at Renovaro Inc include 10 percent owner Anderson Wittekind William , 10 percent owner Ole Abildgaard , and Executive Vice President Francois Binette .
Renovaro Inc (RENB) Insider Trades Summary
Over the past 18 months, Carol L Brosgart made no insider transaction in Renovaro Inc (RENB). Other recent insider transactions involving Renovaro Inc (RENB) include a net sale of 473,180 shares made by Anderson Wittekind William ,
In summary, during the past 3 months, insiders sold 0 shares of Renovaro Inc (RENB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 473,180 shares of Renovaro Inc (RENB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 473,180 shares.
Renovaro Inc (RENB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Renovaro Inc Insider Transactions
Carol L Brosgart Mailing Address
Above is the net worth, insider trading, and ownership report for Carol L Brosgart. You might contact Carol L Brosgart via mailing address: C/o Tobira Therapeutics, Inc., 701 Gateway Boulevard, South San Francisco Ca 94080.